Tafazzin regulates neutrophil maturation and inflammatory response

Authors:

Abstract
Barth syndrome (BTHS) is a rare genetic disease caused by mutations in the TAFAZZIN gene. It is characterized by neutropenia, cardiomyopathy and skeletal myopathy. Neutropenia in BTHS is associated with life-threatening infections, yet there is little understanding of the molecular and physiological causes of this phenomenon. We combined bone marrow analysis, CRISPR/Cas9 genome editing in hematopoietic stem cells and functional characterization of circulating BTHS patient neutrophils to investigate the role of TAFAZZIN in neutrophils and their progenitors. We demonstrate a partial cell intrinsic differentiation defect, along with a dysregulated neutrophil inflammatory response in BTHS, including elevated degranulation and formation of neutrophil extracellular traps (NETs) in response to calcium flux. Developmental and functional alterations in BTHS neutrophils are underpinned by perturbations in the unfolded protein response (UPR) signaling pathway, suggesting potential therapeutic avenues for targeting BTHS neutropenia.
All Related Versions
Funding Information
  • Medical Research Foundation (MR/R02149X/1)
  • Barth Syndrome Foundation
  • GW4-CAT Wellcome Trust Clinical PhD fellowship
  • NHS Blood and Transplant R&D grant (WP15-05)
  • NIHR BTRU in partnership with NHSBT (IS-BTU-1214-10032)
  • Wellcome Trust Dynamic Cell PhD studentship
  • CRUK Scotland Institute core funding (A31287)
  • Bristol and Weston Hospitals Charity

This publication has 67 references indexed in Scilit: